TGM2 and juvenile Huntington disease: Interestingly, in a model of Huntington’s disease, treatment with cystamine delays the onset of motor dysfunction and improves lifespan even in mice that do not express tissue transglutaminase [28], demonstrating anti-transglutaminase-independent effects of cystamine in a mouse model.